Back in the green
According to Reuters, by 08:35 GMT on October 6, the STOXX 600 was up 0.8% at 638.67 points, heading for a third straight day of gains and nearing one-week highs.
The rise was led by healthcare stocks, with the sector index up 1.4%, the biggest gain among European sectors. Investors were awaiting euro zone retail sales data due later in the day, which could offer clues about consumer spending.
Genmab leads healthcare
Genmab shares jumped 7.7% to a three-year high after a combination treatment developed by the Danish company with US drugmaker AbbVie reduced the risk of disease progression or death in patients newly diagnosed with a type of lymphoma in a late-stage study.
The result not only offers new treatment prospects for patients but also strengthens investor confidence in European biotech, a sector with long-term growth potential driven by scientific innovation.
Bonds take a breather
Developments in bond and rate markets were notable during the session:

















